Pharmaceutical Sciences Facult y
|Dr. Mike Crider is Chair of the Department of Pharmaceutical Sciences and Associate Dean of Research. He most recently served as the Department Head of Basic Pharmaceutical Sciences at the University of Louisiana at Monroe where he earned several teaching awards. He earned the B.S. degree in chemistry in 1970 from Murray State University and the Ph.D. degree in medicinal chemistry from the University of Kentucky. Dr. Crider did postdoctoral work in the Department of Medicinal Chemistry at Purdue University followed by a faculty appointment at the University of Toledo. Dr. Crider's research is focused on the development of peptidomimetics and agents acting on the central nervous system.|
|Dr. Gireesh Gupchup , Dean, joined SIUE from the University of New Mexico Health Sciences Center (UNMHSC). There he was Chair of the PharmacoEconomics, Pharmaceutical Policy and Outcomes Research (PEPPOR) Graduate Program and Director of the New Mexico Medicaid Retrospective Drug Utilization Review Program. He was also the First Vice President of the New Mexico Pharmaceutical Association. Dr. Gupchup graduated with the Ph.D. degree in pharmacy practice in 1996 from Purdue University. He holds two master's degrees - one in Administrative Pharmacy and one in Industrial Pharmacy - from the University of Toledo, and a B.S. in Pharmacy from the University of Bombay.|
|Dr. Radhika Devraj , Assistant Professor of Pharmaceutical Sciences received her Ph.D. with an emphasis in Pharmacy Administration from Purdue University. She holds a Master's degree from the University of Toledo, and B.S. in Pharmacy from the University of Bombay. Prior to joining SIUE, she was Research Scientist at BJC HealthCare, Center for Healthcare Quality and Effectiveness, and at Washington University School of Medicine. Her research interests are in the broad area of patient-reported outcomes, and preventable adverse drug events.|
|Dr. Bill Kolling is an Associate Professor of Pharmaceutical Sciences (Pharmaceutics) in the department. He received a B.S. in pharmacy and an M.S. in pharmaceutics from the University of Illinois. He was a pediatric clinical pharmacist at Children's Memorial Hospital in Chicago prior to obtaining his Ph.D. from the University of Iowa. He was on the faculty at the University of Mississippi and the University of Louisiana at Monroe before joining SIUE. His research interests include the use of microemulsions for nanoparticle synthesis, and water vapor sorption by drugs and excipients.|
|Dr. Maria Kontoyianni , Assistant Professor of Pharmaceutical Sciences, received a B.S. in Pharmacy from the University of Athens, Greece, a M.Sc. in Medicinal Chemistry from the University of Illinois Medical Center, Chicago, and a Ph.D. in Medicinal Chemistry with emphasis on Computational Chemistry from the University of North Carolina, Chapel Hill. Her post-doctoral fellowship with Professor Terry Lybrand at the University of Washington, Seattle, focused on Computational Biology. Prior to joining the SIUE School of Pharmacy, she worked in Research and Development of Fortune 500 companies, such as Johnson & Johnson and Procter & Gamble. Dr. Kontoyianni's research interests involve the classification of structural data pertaining to ligand-protein complexes, development of computational tools to better understand ligand recognition by macromolecular targets, and drug discovery approaches to specific disease areas.|
|Dr. Guim Kwon is an Associate Professor of Pharmaceutical Sciences. She comes from Washington University School of Medicine in St. Louis where she was a research instructor in the Department of Pathology. Dr. Kwon received her B.S. in Cellular Molecular Biology from the University of Michigan in 1986, and completed her Ph.D. in Pharmacology at the University of Michigan in 1992. Dr. Kwon completed her postdoctoral training at Washington University School of Medicine and continued to research at the same institution for 12 years. Her research is focused on the dysfunction and destruction of pancreatic ß-cells associated with the development of type 1 and type 2 diabetes.|
Dr. Tim McPherson
, Associate Professor of Pharmaceutical Sciences, received a B.S. in pharmacy degree from St. Louis College of Pharmacy, and a Ph.D. in pharmaceutics from Purdue University. Following a postdoctoral appointment in the Hillenbrand Biomedical Engineering Center at Purdue, Dr. McPherson joined St. Louis College of Pharmacy as Assistant Professor of Pharmaceutics, rising to the rank of Associate Professor of Pharmaceutical Sciences.
His research interests include pharmaceutical and nutraceutical tablet and capsule formulation development, emulsions as drug delivery vehicles, and compounding in the independent community pharmacy practice.
|Dr. Bill Neumann , Assistant Professor of Pharmaceutical Sciences, received a B.S. in Chemistry from the University of Missouri in Columbia in 1983 and a Ph.D. in 1987 from UM-St. Louis where he worked on synthetic methodologies directed at preparing antitumor cyclopentanoid natural products. Since then, Dr. Neumann has conducted research in both the diagnostic imaging and therapeutic pharmaceutical industries. Prior to joining the SIUE School of Pharmacy he spent the majority of his industrial career at Monsanto corporate research and later Pharmacia leading the new synthetic methods group. He is also currently adjunct Professor in the Department of Internal Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, St. Louis University. Dr. Neumann's research interests are primarily in the areas of structure based drug discovery and catalytic antioxidants.|
||Dr. Marcelo Nieto joined the School of Pharmacy at SIUE as Assistant Professor of Pharmaceutical Sciences on October 1, 2006. He received his B.S. in chemistry (Organic Chemistry) from the National University of Córdoba (Argentina). In 1999 he completed his Ph.D. working in the area of design, synthesis and physicochemical studies of fluoroquinolone antimicrobials. After graduating, he moved to the US to work as a postdoctoral researcher in the area of synthesis of antiviral agents based on a natural product at the University of Mississippi, and then he moved up to a research scientist position at the same university. During the last three years, his research was focused on the investigation of the interaction of the non-nitrogenous kappa opioid receptor agents (salvinorin A and analogs) with opioid receptors. He also collaborated in other projects in Dr. Chris McCurdy's research group such as the design and synthesis of nociceptin/orphanin FQ (N/OFQ) non-peptide ligands based on receptor modeling studies. Dr. Nieto's research interests are the design and synthesis of new anti-infective drugs as well as the investigation of new opioid analgesics (synthetic or natural products).|
|Dr. Cathy Santanello , Associate Professor of Pharmaceutical Sciences and the Director of Instructional Strategies, has been at SIUE since 1993. Prior to joining the School of Pharmacy, she served as the Program Director of the Excellence in Learning and Teaching Initiative and an Instructor in the Department of Biological Sciences at SIUE, and as a Microbiologist and Histologist in industry. She received her B.S. degree in Zoology from Eastern IL University in 1979, her M.S. in Biology from Stephen F. Austin State University in 1983, and a Ph.D. in Biology in 1989 from St. Louis University. Cathy's research interests are in Medical Entomology (Lyme disease) as well as the Scholarship of Teaching and Learning.|
|Dr. Joe Schober is an Assistant Professor in the Department of Pharmaceutical Sciences. After receiving a B.S. degree from the University of Illinois at Springfield he was a practicing Clinical Laboratory Scientist from 1994 to 1996. He received a Ph.D. from the Department of Pharmacology, University of Illinois at Chicago (UIC) in 2003. His research at UIC focused on the interaction of monocyte integrin receptors with novel extracellular matrix proteins expressed in atherosclerotic lesions. Dr. Schober was an American Heart Association postdoctoral fellow at Northwestern University, Department of Cell and Molecular Biology, Chicago where his research project included investigation of cytoskeleton dynamics and cell motility using quantitative fluorescence microscopy. His current research at SIUE involves determining significance of microtubule-associated proteins in cell-matrix interaction, cell-cell junctions and cell movement.|
Dr. Walter Siganga , Professor of Pharmaceutical Sciences, joined the SIUE School of Pharmacy from the University Of Toledo College Of Pharmacy where he was a faculty member in Pharmacy Administration. He is a graduate of Howard University where he received his B.S. Pharmacy degree in 1984. He proceeded to complete a Masters Degree in Pharmaceutical Administration at the Ohio State University in 1986 and obtained a Ph.D. in Pharmacy Administration from the University of Maryland at Baltimore in 1992. He is a registered pharmacist with working experience primarily in community pharmacy. His research interests include health policy, pharmacoeconomics and health economics, pharmacy education, and differential access to health care.
|Dr. Ken Witt , Associate Professor of Pharmaceutical Sciences, received his B.S. in chemistry in 1994 from Northern Michigan University and the Ph.D. in pharmacology and toxicology from the University of Arizona in 2001. He served as a research fellow at the University of Arizona, College of Medicine through 2005. Dr. Witt's research is focused on the blood-brain barrier, specific to pathophysiological assessment of the tight junctional complex, as well as CNS drug delivery.|
|Dr. Ron Worthington , Associate Professor of Pharmaceutical Sciences, received the A.B. and Ph.D. degrees from Washington University. After postdoctoral appointments at Washington University, G.D. Searle, and Texas Tech University, he assumed a faculty position in the College of Medicine at the University of Tennessee Medical Center, followed by a position at G.D. Searle as a senior research scientist. In March 2005, Dr. Worthington joined the SIUE School of Pharmacy from Divergence, Inc. in St. Louis, where he was employed as a senior research scientist in bioinformatics. Dr. Worthington will teach biochemistry and biotechnology in the Pharm D. program at SIUE. His research is focused in the areas of pharmacogenomics and bioinformatics.|